CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CO-TRANS-NET project develops synthetic nucleic acids that can detect various tumor biomarkers, enabling simultaneous cancer diagnosis and therapy. This innovative approach utilizes cell-free systems to create responsive networks for improved patient care.
WHY:
The heterogeneity of tumors often makes their diagnosis and treatment a very hard task. A single tumor can have many different diagnostically-relevant molecular markers which can also be used to monitor the efficacy of treatment.
Innovative, simple, cost-effective, and quantitative analytical tools for diagnostic and therapeutic applications are urgently needed to ensure rapid and appropriate patient care.WHAT:
CO-TRANS-NET project addresses this need by developing synthetic nucleic acid un…
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
